Littleton, MA, United States of America

Kostas Saranteas

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kostas Saranteas: Innovator in Pharmaceutical Salts

Introduction

Kostas Saranteas, an inventive mind based in Littleton, MA (US), has made significant contributions to the field of pharmaceuticals through his innovative work on salts and their production methods. With one patent to his name, Kostas has demonstrated a commitment to advancing medicinal chemistry and improving drug formulations.

Latest Patents

Kostas holds a patent titled "Salts, crystal forms, and production methods thereof." This patent encompasses salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various crystal forms, along with the compositions, medicaments, and pharmaceutically acceptable formulations associated with them. Moreover, it provides methods for creating such salts and modulating their particle size distributions, enhancing their applicability in medicinal contexts.

Career Highlights

Throughout his career, Kostas has been associated with Sumitomo Pharma America, Inc., a company renowned for its focus on pharmaceutical development and innovation. His role within the organization highlights his expertise in drug formulation and chemical synthesis, essential areas for the advancement of healthcare solutions.

Collaborations

Kostas has had the opportunity to work alongside esteemed colleagues such as Andrea Bauer and Nandkumar Nivritti Bhogle. These collaborations underscore the interdisciplinary efforts vital for successful innovation in the pharmaceutical industry, as combined knowledge and skills lead to enhanced research outcomes.

Conclusion

Kostas Saranteas stands as an example of how individual inventors can make a substantial impact on the pharmaceutical field. His patent on salts and their formulations highlights a focused approach to drug development that has the potential to improve patient outcomes significantly. As he continues his work at Sumitomo Pharma America, Inc., the innovations stemming from his research will undoubtedly contribute to the ongoing evolution of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…